Product NDC: | 47335-289 |
Proprietary Name: | CAFFEINE CITRATE |
Non Proprietary Name: | CAFFEINE CITRATE |
Active Ingredient(s): | 20 mg/mL & nbsp; CAFFEINE CITRATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 47335-289 |
Labeler Name: | Sun Pharma Global FZE |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090077 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091001 |
Package NDC: | 47335-289-40 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (47335-289-40) > 3 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 47335-289-40 |
Proprietary Name | CAFFEINE CITRATE |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (47335-289-40) > 3 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 47335-289 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CAFFEINE CITRATE |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091001 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharma Global FZE |
Substance Name | CAFFEINE CITRATE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |